In the TMA cohort, univariate analysis found that high expression of Prp19 was a risk factor both for OS (p = 0.010; HR = 5.189) and EFS (p = 0.045; HR = 2.644) in children with neuroblastoma (Table 3). This evidence concerns the gene PRPF19 and neuroblastoma.